MEPIVACAINE HYDROCHLORIDE W Drug Patent Profile
✉ Email this page to a colleague
When do Mepivacaine Hydrochloride W patents expire, and when can generic versions of Mepivacaine Hydrochloride W launch?
Mepivacaine Hydrochloride W is a drug marketed by Belmora Llc and is included in one NDA.
The generic ingredient in MEPIVACAINE HYDROCHLORIDE W is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPIVACAINE HYDROCHLORIDE W?
- What are the global sales for MEPIVACAINE HYDROCHLORIDE W?
- What is Average Wholesale Price for MEPIVACAINE HYDROCHLORIDE W?
Summary for MEPIVACAINE HYDROCHLORIDE W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MEPIVACAINE HYDROCHLORIDE W at DailyMed |
US Patents and Regulatory Information for MEPIVACAINE HYDROCHLORIDE W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belmora Llc | MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN | levonordefrin; mepivacaine hydrochloride | INJECTABLE;INJECTION | 084850-002 | Oct 21, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
